Santa Cruz Sentinel from Santa Cruz, California on December 1, 2002 · Page 30
Get access to this page with a Free Trial

Santa Cruz Sentinel from Santa Cruz, California · Page 30

Santa Cruz, California
Issue Date:
Sunday, December 1, 2002
Page 30
Start Free Trial

B-8 SANTA CRUZ SENTINEL Sunday, December 1, 2002 t fcland's genetics-mapping frenzy leaves some cold Science historian debunks national notion that Viking genes hold key to curing disease, creating drugs By JILL LAWLESS THE ASSOCIATED PRESS ; REYKJAVIK, Iceland - Steindor Erlingsson feels like the least popular man in Iceland. The 36-year-old science historian has just published a book debunking the newest national notion, that Icelanders' Viking genes hold the key to curing diseases, developing new drugs and making the country rich. "My family and friends tell me this book might ruin my career possibilities in Iceland," said Erlingsson, running a hand across a stubbly beard. "In a small society like this, you can't hide anywhere." , Erlingsson's target is deCODE Genetics, the biotechnology company set up in 1996 to scour the country's genes for keys to disease. The company's charismatic founder, Kari Stefansson, said Icelanders' detailed family trees and common descent from 9th century Norwegian settlers formed a rich scientific resource that could unlock the secrets of cancer, mental illness and other devastating diseases. Since scientists study family histories to track the route a disease-causing gene has taken, the theory runs that in Iceland they would have a sort of extended family of the entire population 280,000 people to work with. "Our Genes," Erlingsson's just-released Icelandic-language book, accuses deCODE of shaky science, bad ethics and overly cosy ties with Iceland's politicians. But Icelanders a small, closely knit population with a strong pride in their roots embraced the project from the start. Eighty thousand people gave blood samples. Thousands bought shares in the firm before it went public on the Nasdaq exchange two years ago. Icelandic banks sold shares on the "gray market" for more than $60 each. "This gene frenzy was going on in Iceland," said Erlingsson. "DeCODE was in the news every day. People were taking out loans to buy these stocks." Many now wish they hadn't. The heroic deCODE project is looking increasingly fallible. : y i Steindor Erlingsson holds a copy of his book, 'Our Genes,' in Reykjavik, Iceland, last month. The 36-year-old science historian debunked the newest notion that Icelanders' Viking genes hold the key to curing disease. amassed a vast amount of information on Icelanders. It says it has mapped genes linked to 25 diseases and isolated genes associated with increased susceptibility to seven ailments, including strokes and schizophrenia. CEO Stefansson, a former Harvard The company has yet to make a profit. On Nov. 15 it announced a third-quarter net loss of $85.7 million. It recently laid off 200 people, almost a third of the total, at its Reykjavik genetics lab. Nonetheless, the company has Maximize your available co-op funds to grow your business! 2002 unspent co-op accruals will disappear on December 31st. By investing these additional dollars your ads can have greater impact through increasing the size and frequency. Consult your Sentinel sales representative to help you work these unspent funds into your year-end advertising plan. We'll provide proof of publication tear sheets and invoices making it easy for you to submit your claims. Call today! Sue Lamothe Karen Olsen Sue Procise Janet Crosse 429-2437 429-2476 429-2441 429-2484 Joyce Davis Kate Kauffman Tina Musgrave or call 429-2431 429-2435 429-2416 429-2434 Santa Cruz Sentinel 4S5 Mm iIC 'tss&tts&p aw.308os 7 p.m. Doors open 7:30p.m. Grand Buffet & Dinner Entertainment 9 p.m.-i a.m. Dancing io p.m. Dessert Extravaganza 12 Midnight Countdown, Balloon Drop & Champagne Toast Dinner & Dancing $89 per person Dessert & Dancing $59 per person in advance $69 per person at the door Full bar-21 & over 'Includes tax & gratuity To purchase tickets call (831) 423-2053 Cocoanut Grove, 400 Beach Street, Santa Cruz, CA 95060 Cocoanut Grove Santa Cruz neuroscience professor, says the company's approach has been a "smashing success." Announcing the latest financial results, Stefansson said deCODE was "making the transition from a discovery-based company to a company based on product development ... from gene discovery to drug development." The company says it will break even by the end of 2003, but its shares, which debuted on the Nasdaq in July 2000 at $18 each, are worth about $2.50 now, swamped in the stock market gloom that has hit the high-tech industry as a whole. "When it was going on, if you went to a bank or a trading company, everybody said, 'Whatever you do, buy deCODE,'" said Jon Eldjarn Bjarnason, a 38-year-old fishing-boat engineer. "Everybody who could loan you money was encouraging you to buy deCODE. A lot of people put everything into it. Now they have no money, nothing." Bjarnason was lucky. With debts mounting from other investments, he sold his deCODE shares at $48 just before the company went public. A lot of people he knows did not and now are too embarrassed to speak to the press. "I sold early. I was broke. I was lucky," he said. "My mother had a 2 million krona ($20,000) loan and bought shares at $24. When they were at $64, she asked the bank if she should sell; they said no, it's going to be $100. Now she's stuck with them at $2 a share, and the bank says it wants the loan back." Meanwhile, Bjarnason's other hightech investments have tanked, driving him to the edge of bankruptcy. rrrni? in .nnti-not nnnearS to have flourished. Founded in 1996 with 20 employees and $12 million from venture capitalists, the company now employs 450 people and has a shiny new wood-and-glass headquarters in Reykjavik. In 1998, deCODE signed a deal worth up to $200 million with Swiss pharmaceuticals giant Roche to look for genes that cause 12 common diseases. In September it linked up with U.S. pharmaceutical company Merck to develop anti-obesity drugs. In May, Iceland's parliament, the Althingi, agreed to guarantee a $200 million bond issue as deCODE seeks more investment to develop new drugs. The company says a breakthrough is only a matter of time. Meanwhile, the economic fallout has heightened criticism of deCODE's close relationship with Iceland's government. "The difference between deCODE and other genomics companies is that they are located in one of the smallest economies in the world, and the government has done everything to help them," said Erlingsson, the "Our Genes" author. Prime Minister David Oddsson appeared frequently with Stefansson in the company's early days. In 1998, parliament passed a law allowing a private company deCODE, though no specific company was named to obtain medical records from everyone in the country. Consent was assumed unless people opted out. Many doctors and medical ethicists were alarmed. "Patients ask me: 'What will happen to my data? Will it end up in the hands of deCODE? What will happen to my blood? Will it be used against me?'," said Petur Hauksson, a physician who heads the Association of Icelanders for ttnics in ocience ana Medicine a group of anti deCODE scientists. "Having these valuable records in the hands of a private company is worrying." Others criticize the company's scientific approach, which uses "population genomics" to study the genetic causes of disease. The company says Iceland's advantage is its detailed mprli genealogical records and the relative homogeneity of its small population. It's estimated there have been fewer Kan 1 million InnlnnJnHn t 1 ii-oianucis suiue worse settlers first arrived on the North Atlantic island. narrtrti?iiFnoin.. i . woo lamiLiieu wun pians 10 build linked databases of medical records, family trees and DNA samples to create a genetic roadmap that could be searched for disease-linked genes.- Some scientists say Iceland's genetic purity is a myth. They say the island ' was actually settled by a mixture of Scandinavians and Celts and is just as ' genetically varied as most European countries. "We are not as homogenous as we were meant to be, blue-eyed and blonde," said Hauksson. "We were valuable because we were willing to participate." While deCODE remains publicly con-' fident, it has had to change its corporate game plan. The database of med-. ical records that the 1998 law was designed to establish does not yet exist and may never be completed. More . than 20,000 Icelanders have opted out. And on Nov. 14, talks collapsed '"""'Vii vii-.i aim iiicuiu o lai gcoi hospital over a plan to share medical records. European Facials Sun Damage Acne Treatments ; Microdermabrasion i Vitamin Treatments Collagen Treatments - Botox Treatments " Enzyme Treatments " Dermal Rejuvenation v Facial Toning UltraSound Facial Treatment Permanent Make-up P Brow Lash Tinting Waxing Reflexology . i 'i Warm Stone Massage ' Cranial Sacral Therapy .' Lymphatic Facial Massage Lomi Lomi Hawaiian Therapy , Swedish Massage ' Pure Skin proudly features Sothys Glymed Plus Cellex-C Shanda Thomas, Jennifer Heath & Deborah Polverino invite you to their,.. GRAND OPENING CELEBRATION Sunday Dec. 8th from 4-6 p.m. Come enjoy hors d'oeuvres, and refreshments with a tour of their new skin care salon. GRAND OPENING SPECIAL facial wone hour warm stone massage for $125.00 (value $200.00) Exp.123102 Holiday Gift Certificates Available t t' " l V E M 6 4 H . i t tl I 1 Call now to book your first appointment... LZl ykin 4170 Gross Road Extension, Capitola, Ca 95010 I Stop by our table this week Friday Saturday Sunday Santa Cruz Sentinel TWO LOCATIONS: 1702 Freedom Blvd. Freedom 2600 41st Ave. Soquel See Kmart's insert in the Sentinel every week for Sunday & Monday Special Buys Santa Cruz Sentinel Your news. Your stories. Every day

Get access to

  • The largest online newspaper archive
  • 18,000+ newspapers from the 1700s–2000s
  • Millions of additional pages added every month

Try it free